Home » Oncology » IRIS trial: Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase CML

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Subscribe via email